ARUNA AGNI: Open Payments
NPI 1801917786 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,688 in 153 payments from 10 companies in 2025. Trend: 2023 $3,754 · 2024 $4,328 · 2025 $4,688
Food & beverage: $4,458Education: $230
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $1,138 |
| Teva Pharmaceuticals USA, Inc. | 26 | $1,048 |
| ABBVIE INC. | 24 | $720 |
| Alkermes, Inc. | 22 | $590 |
| E.R. Squibb & Sons, L.L.C. | 14 | $343 |
| Otsuka America Pharmaceutical, Inc. | 7 | $279 |
| Neurocrine BioSciences, Inc. | 12 | $269 |
| Vanda Pharmaceuticals Inc. | 16 | $195 |
| Lundbeck LLC | 3 | $82 |
| Validus Pharmaceuticals LLC | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, ARISTADA, COBENFY, REXULTI, UZEDY, INGREZZA.
Industry payments across NY — which companies pay providers there.
